Swiss, a third-generation family-owned business, leverages over 25 years of expertise in generic and specialty pharmaceuticals. Our proficiency extends to the development and manufacturing of a diverse range of sterile dosage forms. Operating globally, we export our products under our brand name, reaching over 80 countries. Our commitment extends to providing tailored services to distribution partners, offering comprehensive analytical support at our cGMP production facilities. Holding approvals from regulatory bodies such as EUGMP, Brazilian Anvisa, Mexican Cofepris, Australian TGA, and PIC/s, our facilities adhere to the highest standards. With a robust portfolio, we boast over 1,000 approved dossiers encompassing approximately 190 unique molecules, spanning both regular and complex dosage forms.
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Limited government data available — 5 criteria met